Table 1 Patient characteristics (N = 3,408)
n | % | |
|---|---|---|
Sociodemographic characteristics | ||
Age at survey, mean (SD), y | 78.8 | 6.5 |
Level of education | ||
Low | 1179 | 38.9 |
Intermediate | 537 | 17.7 |
High | 377 | 12.4 |
Tertiary | 940 | 31.0 |
Partnership | 2635 | 86.6 |
Children | 3010 | 88.7 |
Clinicopathological parameters | ||
Years since RP, mean (SD), y | 16.5 | 3.8 |
Positive PC family history | 1364 | 40.0 |
Secondary cancer | 416 | 12.2 |
PSA at diagnosis, mean (SD), ng/ml | 7.2 | 6.0 |
Organ defined disease at RP | 2420 | 71.5 |
Lymph node invasion at RP | 133 | 3.9 |
Distant Metastasis at RP | 1 | 0.03 |
Biochemical recurrence | 1239 | 36.4 |
Current therapy | 368 | 10.8 |
Androgen deprivation therapy | 364 | 98.9 |
Chemotherapy | 3 | 0.8 |
Radiation therapy | 5 | 1.3 |
Psychological parameters and HRQoL | ||
Decision regret | ||
Yes | 373 | 10.9 |
No | 3035 | 89.1 |
Treatment decision making | ||
Active | 912 | 27.0 |
Shared | 2094 | 61.9 |
Passive | 376 | 11.1 |
HRQoL, mean (SD) | 69.5 | 19.3 |
PC anxiety, mean (SD) | 2.6 | 3.0 |
PSA anxiety, mean (SD) | 0.4 | 1.1 |
Depression (PHQ), mean (SD) | 1.0 | 1.2 |
Anxiety (GAD-2), mean (SD) | 0.8 | 1.1 |